Purified mulberry twig alkaloids regulate sex hormones, normalize estrous cycles, and reduce ovarian cyst-like changes in PCOS.
Targeting TMC5 with small molecules or siRNA enables reversible non-hormonal fertility control and supports male infertility diagnosis.
Fraxetin inhibits endometrial cell growth and migration while promoting apoptosis, offering endometriosis treatment with fewer side effects.
An optimized FGFR-targeting compound addresses insufficient efficacy in triple-negative breast cancer and reduces tumor volume.
Divided cabergoline dosing during gestation reduces lactation while maintaining fetal safety.
Administering Bay 11-7082 reduces fibroid size by blocking inflammatory pathways, avoiding hormonal side effects.
A multi-herb TCM compound up-regulates PI3K and p-AKT expressions to enhance testosterone levels.
Putrescine administration reduces aneuploid pregnancy risk by restoring ovarian ornithine decarboxylase activity and preventing harmful embryo defects.
A herbal composition preserves nitric oxide levels and inhibits phosphodiesterase-5 to enhance erectile function.
A beverage combines specific fatty acids with masking agents to increase testosterone release through systemic absorption.
Administering let-7 microRNA activators reduces lesion size and inflammation without systemic hormonal side effects or fertility compromise.
Sea buckthorn extracts mediate chemo effects to preserve ovarian reserve and restore estrous cycles.
Gene expression profiling replaces invasive cervical cerclage with pharmacological reversal of sPTB molecular signatures.
Dopamine receptor agonist cabergoline prevents metabolic diseases and reproductive disorders during shortened dry periods while maintaining milk quality.